These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Diabetic ketoacidosis after steroid administration for bronchopulmonary dysplasia: a case report. Spear ML; Reeves G; Pearlman SA J Perinatol; 1993; 13(3):232-4. PubMed ID: 8345389 [No Abstract] [Full Text] [Related]
47. Postnatal corticosteroids for preterm infants--do what we say, not what we do. Jobe AH N Engl J Med; 2004 Mar; 350(13):1349-51. PubMed ID: 15044647 [No Abstract] [Full Text] [Related]
48. Left ventricular hypertrophy with outflow tract obstruction-a complication of dexamethasone treatment for subglottic stenosis. Balys R; Manoukian J; Zalai C Int J Pediatr Otorhinolaryngol; 2005 Feb; 69(2):271-3. PubMed ID: 15656964 [TBL] [Abstract][Full Text] [Related]
49. Hypertrophic intraventricular flow obstruction after very-low-dose dexamethasone (Minidex) in preterm infants: case presentation and review of the literature. Paech C; Wolf N; Thome UH; Knüpfer M J Perinatol; 2014 Mar; 34(3):244-6. PubMed ID: 24573211 [TBL] [Abstract][Full Text] [Related]
50. Postnatal steroids for the treatment of bronchopulmonary dysplasia: a complex case presentation. Forest S J Perinat Neonatal Nurs; 2011; 25(3):283-91; quiz 292-3. PubMed ID: 21825919 [TBL] [Abstract][Full Text] [Related]
51. Effect of dexamethasone on leukocyte numbers and lymphocyte-blastogenic responses to mitogens in infants with bronchopulmonary dysplasia. Moya FR; Becerra M; Leiva L; Sorensen RU Clin Pediatr (Phila); 1993 Mar; 32(3):185-8. PubMed ID: 8453841 [No Abstract] [Full Text] [Related]
52. Evidence-Based Pharmacologic Therapies for Prevention of Bronchopulmonary Dysplasia: Application of the Grading of Recommendations Assessment, Development, and Evaluation Methodology. Jensen EA; Foglia EE; Schmidt B Clin Perinatol; 2015 Dec; 42(4):755-79. PubMed ID: 26593077 [TBL] [Abstract][Full Text] [Related]
53. Steroids, chronic lung disease, and retinopathy of prematurity. Ehrenkranz RA Pediatrics; 1992 Oct; 90(4):646-7. PubMed ID: 1408525 [No Abstract] [Full Text] [Related]
54. [Effect of dexamethasone and spironolactone therapy in calcium and phosphate homeostasis in premature infants with a birth weight under 1,500 g]. Sonntag J; Gaude M Klin Padiatr; 1998; 210(5):354-7. PubMed ID: 9782479 [TBL] [Abstract][Full Text] [Related]
55. Postnatal dexamethasone for lung disease of prematurity. Watchko JF; Brozanski BS N Engl J Med; 2004 Jun; 350(26):2715-8; author reply 2715-8. PubMed ID: 15218577 [No Abstract] [Full Text] [Related]
57. Bronchopulmonary dysplasia: treatment success with dexamethasone. Hearne AB J Natl Med Assoc; 1982 Aug; 74(8):795-800. PubMed ID: 7131578 [TBL] [Abstract][Full Text] [Related]
58. Steroid therapy and the treatment of bronchopulmonary dysplasia: an error in neonatology, or an unavoidable therapeutic intervention? Kaplan M J Perinatol; 2004 Feb; 24(2):127-8; author reply 128-9. PubMed ID: 14872210 [No Abstract] [Full Text] [Related]
59. [Bronchopulmonary dysplasia. Retrospective analysis of various forms of treatment and development of a staged therapeutic plan]. Bauer J; Beedgen B; Böhler T; Sontheimer D; Zilow EP; Linderkamp O Klin Padiatr; 1996; 208(2):56-60. PubMed ID: 8901183 [TBL] [Abstract][Full Text] [Related]
60. Dexamethasone therapy for bronchopulmonary dysplasia. Kramer LI Va Med Q; 1994; 121(4):239-40, 244. PubMed ID: 7948077 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]